The meta-analysis conducted in 2012 was found that GSTM1 null genotype, GSTM1 and GSTT1 double null genotype or GSTT1 null genotype and rs1695 polymorphism within the GSTP1 gene can correlate with an increased risk of cancer development [45]. The gene discussed is GSTM1; the disease is cancer.